Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
- 10 September 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (22), 13578-13594
- https://doi.org/10.1021/acs.jmedchem.0c01170
Abstract
SHP2 is a nonreceptor protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also plays an important role in the programed cell death pathway (PD-1/PD-L1). As an oncoprotein as well as a potential immunomodulator, controlling SHP2 activity is of high therapeutic interest. As part of our comprehensive program targeting SHP2, we identified multiple allosteric binding modes of inhibition and optimized numerous chemical scaffolds in parallel. In this drug annotation report, we detail the identification and optimization of the pyrazine class of allosteric SHP2 inhibitors. Structure and property-based drug design enabled the identification of protein-ligand interactions, potent cellular inhibition, control of physicochemical, pharmaceutical and selectivity properties, and potent in vivo antitumor activity. These studies culminated in the discovery of TNO155, (3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine (1), a highly potent, selective, orally efficacious, and first-in-class SHP2 inhibitor currently in clinical trials for cancer.Keywords
This publication has 51 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)Journal of Medicinal Chemistry, 2010
- XDSActa crystallographica. Section D, Structural biology, 2010
- Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumorsOncogene, 2008
- An Improved Cu-Based Catalyst System for the Reactions of Alcohols with Aryl HalidesThe Journal of Organic Chemistry, 2007
- Protein tyrosine phosphatase function: the substrate perspectiveBiochemical Journal, 2007
- PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphataseBlood, 2006
- A SHPing tale: Perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tailCellular Signalling, 2005
- Facile Introduction of SH Group on Aromatic Substrates via Electrophilic Substitution ReactionsThe Journal of Organic Chemistry, 2003